Formic Acid Phenyl Ester

Formic Acid Phenyl Ester

SCHEMBL4878385

CCCC.NC(O)=S.NC(O)=S.O=COc1ccccc1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 1/20 0.36
MAPT P10636 2/20 0.36
ALOX12 P18054 1/20 0.36
PARP10 Q53GL7 2/20 0.35
LTA4H P09960 1/20 0.34
AOC3 Q16853 2/20 0.34
HPGD P15428 1/20 0.34
MAOB P27338 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid Phenyl Ester SCHEMBL4873074 0.91 PARP10 (0.37) CTNNB1PARP10AOC3MAOBALDH1A1
Formic Acid Phenyl Ester SCHEMBL4428540 0.86 PARP10 (0.34) CTNNB1MAPTPARP10AOC3MAOB
Formic Acid Phenyl Ester SCHEMBL28329438 0.81 LTA4H (0.48) LTA4HALDH1A1GAAHTTLMNA
Formic Acid Phenyl Ester SCHEMBL27930651 0.78 TSHR (0.41) PARP10LTA4HAOC3MAOBALDH1A1
Formic Acid Phenyl Ester SCHEMBL27835860 0.78 CA4 (0.43) LTA4HMAOBALDH1A1GAAKMT2A
Formic Acid Phenyl Ester SCHEMBL27326128 0.78 LTA4H (0.45) LTA4HMAOBALDH1A1GAAKMT2A
Formic Acid Phenyl Ester SCHEMBL2662 0.78
Formic Acid Phenyl Ester SCHEMBL28738736 0.77 CA4 (0.44) LTA4HAOC3HPGDMAOBALDH1A1
Formic Acid Phenyl Ester SCHEMBL30093829 0.77 MTNR1A (0.40) MAPTALDH1A1GAAKMT2A
Formic Acid Phenyl Ester SCHEMBL10906188 0.76 TSHR (0.43) LTA4HMAOBALDH1A1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2117718-B1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICATION OF MINERAL ORE BODIES CYTEC TECH CORP (US) 2017-05-10 EP disclosed
US-8376142-B2 Dithiocarbamate collectors and their use in the beneficiation of mineral ore bodies CYTEC TECHNOLOGY CORP. (US) 2013-02-19 US disclosed
US-20080185317-A1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES CYTEC TECHNOLOGY CORP. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080185317-A1 NOVEL DITHIOCARBAMATE COLLECTORS AND THEIR USE IN THE BENEFICIATION OF MINERAL ORE BODIES FTH1, FECH, SLC40A1 CTNNB1 4649/4885MAPT 1582/4885ALOX12 3269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.